2022
DOI: 10.1093/ckj/sfac027
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19-associated pulmonary aspergillosis in hemodialysis patients

Abstract: Background Coronavirus Disease 2019-associated pulmonary aspergillosis (CAPA) is a fatal complication in the general population. However, there are few reports on CAPA in patients undergoing hemodialysis (HD). Methods This retrospective observational cohort study was conducted at a single center between December 2020 and June 2021. We enrolled 21 HD patients with Coronavirus Disease 2019 (COVID-19) undergoing treatment and di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 27 publications
1
3
0
Order By: Relevance
“…In our study, the 30-day and all-cause mortality rates for COVID-19 were 7.8% and 11.8% in hospitalized HD patients (mean age, 76 years) during the Omicron epidemic. In our previous study of hospitalized HD patients (mean age, 73 years) during the pre-Omicron period, the 90-day mortality rate for COVID-19 was 19.0% [21]. Considering the difference in age, the trends in our study are consistent with the aforementioned study.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…In our study, the 30-day and all-cause mortality rates for COVID-19 were 7.8% and 11.8% in hospitalized HD patients (mean age, 76 years) during the Omicron epidemic. In our previous study of hospitalized HD patients (mean age, 73 years) during the pre-Omicron period, the 90-day mortality rate for COVID-19 was 19.0% [21]. Considering the difference in age, the trends in our study are consistent with the aforementioned study.…”
Section: Discussionsupporting
confidence: 90%
“…Pharmacological treatment for COVID‐19 was performed according to the disease severity as follows: antiviral agents (mild, remdesivir or molnupiravir; moderate–severe, remdesivir; critical, no); monoclonal antibody (mild–severe, sotrovimab [Day 1: 500 mg]; critical, no); prednisolone (mild–moderate, no; severe, intravenous or oral [Days 1–3: 40 mg; Day 4: 30 mg; Day 5: 20 mg; Day 6: 10 mg; the dosage or duration was reduced when the patient weighed <60 kg or oxygenation improved]; critical, intravenous [Days 1–5: 40 mg; Days 6–7: 30 mg; Days 8–9: 20 mg; Days 10–11: 10 mg]); antibiotics and antithrombotic agents (administered at the discretion of the attending physician). Antifungal agents were administered at the discretion of the attending physician when (1, 3)‐β‐ d ‐glucan results were positive [21].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations